Free Trial

TransMedics Group (TMDX) Earnings Date, Estimates & Call Transcripts

TransMedics Group logo
$80.48 -7.88 (-8.92%)
(As of 11/15/2024 ET)

TransMedics Group Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 24Estimated
Actual EPS
(Oct. 28)
$0.12 Missed By -$0.17
Consensus EPS
(Oct. 28)
$0.29

TransMedics Group issued Q3 2024 earnings on October 28, 2024, reporting an EPS of $0.12, which missed analysts' consensus estimates of $0.29 by $0.17. Quarterly revenue rose 63.7% year-over-year to $108.76 million, below analyst estimates of $115 million. With a trailing EPS of $0.94 and a P/E Ratio of 85.62, TransMedics Group's earnings are expected to grow 50.47% next year, from $1.07 to $1.61 per share.

TMDX Upcoming Earnings

TransMedics Group's next earnings date is estimated for Monday, February 24, 2025, based off prior year's reporting schedules.


Skip Charts & View Estimated and Actual Earnings Data

TMDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TMDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

TransMedics Group Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.19-$0.03-$0.11
Q2 20242-$0.09$0.10$0.01
Q3 20242$0.03$0.06$0.05
Q4 20242$0.22$0.22$0.22
FY 20248-$0.03$0.35$0.16
Q1 20251$0.35$0.35$0.35
Q2 20251$0.44$0.44$0.44
Q3 20251$0.45$0.45$0.45
Q4 20251$0.50$0.50$0.50
FY 20254$1.74$1.74$1.74

TransMedics Group Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/24/2025
(Estimated)
------- 
10/28/2024Q3 2024$0.29$0.12 -$0.17$0.12$115.00M$108.76M    
7/31/2024Q2 2024$0.21$0.35+$0.14$0.35$98.84M$114.30M      
4/30/2024Q1 2024-$0.05$0.35+$0.40$0.35$83.78M$96.90M      
2/26/2024Q4 2023-$0.10$0.12+$0.22$0.12$68.49M$81.20M      
11/6/2023Q3 2023-$0.18-$0.12+$0.06$0.54$48.05M$66.43M  
8/3/2023Q2 2023-$0.15-$0.03+$0.12-$0.03$42.42M$42.46M      
Crypto’s Hidden Gem: The missing piece no one’s talking about (Ad)

You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.

Click Here to get the full details about Crypto’s Hidden Gem
5/1/2023Q1 2023-$0.25-$0.08+$0.17-$0.08$36.05M$41.60M      
2/22/2023Q4 2022-$0.28-$0.21+$0.07-$0.21$23.60M$31.38M      

TransMedics Group Earnings - Frequently Asked Questions

TransMedics Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates. Learn more on TMDX's earnings history.

TransMedics Group issued an update on its FY 2024 earnings guidance on Monday, October, 28th. The company issued revenue guidance of $425.0 million-$445.0 million, compared to the consensus revenue estimate of $444.4 million.

In the previous quarter, TransMedics Group (NASDAQ:TMDX) missed the analysts' consensus estimate of $0.29 by $0.17 with a reported earnings per share (EPS) of $0.12. Learn more on analysts' earnings estimate vs. TMDX's actual earnings.

The conference call for TransMedics Group's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for TransMedics Group's latest earnings report can be read online.
Read Transcript

TransMedics Group (NASDAQ:TMDX) has a recorded annual revenue of $401.09 million.

TransMedics Group (NASDAQ:TMDX) has a recorded net income of -$25.03 million. TMDX has generated $0.94 earnings per share over the last four quarters.

TransMedics Group (NASDAQ:TMDX) has a trailing price-to-earnings ratio of 85.62 and a forward price-to-earnings ratio of 75.21.

TransMedics Group's earnings are expected to grow from $1.07 per share to $1.61 per share in the next year, which is a 50.47% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:TMDX) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners